Table 4.
Metabolites significantly associated with NDM/LDM and with a circulating marker of carbamylation.
β ± SE | p-Value | q-Value | |
---|---|---|---|
C-glycosyltryptophan | 0.2 ± 0.0 | 8.8E − 07 | 2.2E − 05 |
Erythronate | 0.1 ± 0.0 | 1.6E − 06 | 3.5E − 05 |
N1-methyladenosine | 0.2 ± 0.0 | 1.1E − 05 | 0.0001 |
N-acetylthreonine | 0.1 ± 0.0 | 1.1E − 05 | 0.0001 |
Pseudouridine | 0.1 ± 0.0 | 1.8E − 05 | 0.0002 |
2-Hydroxyisobutyrate | 0.1 ± 0.0 | 2.3E − 05 | 0.0003 |
N-acetylalanine | 0.2 ± 0.0 | 2.6E − 05 | 0.0003 |
2-Methylbutyroylcarnitine | 0.1 ± 0.0 | 0.0002 | 0.002 |
4-Acetamidobutanoate | 0.1 ± 0.0 | 0.0002 | 0.002 |
Threitol | 0.1 ± 0.0 | 0.0002 | 0.002 |
N-formylmethionine | 0.i ± 0.0 | 0.0002 | 0.002 |
Glutamine | − 0.2 ± 0.0 | 0.0004 | 0.003 |
Myo-inositol | 0.1 ± 0.0 | 0.0004 | 0.003 |
Urea | 0.1 ± 0.0 | 0.001 | 0.007 |
Phenylacetylglutamine | 0.0 ± 0.0 | 0.001 | 0.007 |
Tiglyl carnitine | 0.1 ± 0.0 | 0.001 | 0.008 |
Erythritol | 0.1 ± 0.0 | 0.001 | 0.008 |
Arabonate | 0.0 ± 0.0 | 0.003 | 0.01 |
Glutaroyl carnitine | 0.1 ± 0.0 | 0.003 | 0.01 |
Isobutrylcarnitine | 0.0 ± 0.0 | 0.003 | 0.01 |
Dimethylglycine | 0.1 ± 0.0 | 0.003 | 0.01 |
Serine | − 0.1 ± 0.0 | 0.01 | 0.05 |
N-acetylserine | 0.1 ± 0.0 | 0.01 | 0.05 |
Methylglutarylcarnitine | 0.0 ± 0.0 | 0.02 | 0.05 |
Asparagine | − 0.1 ± 0.0 | 0.02 | 0.06 |
Glucuronate | 0.0 ± 0.0 | 0.02 | 0.07 |
Indolelactate | 0.0 ± 0.0 | 0.02 | 0.07 |
N6-acetyllysine | 0.1 ± 0.0 | 0.02 | 0.07 |
Arabitol | 0.1 ± 0.0 | 0.02 | 0.07 |
Phenol sulfate | 0.0 ± 0.0 | 0.03 | 0.07 |
Cis-4-decenoyl carnitine | 0.0 ± 0.0 | 0.03 | 0.08 |
Butyrylcarnitine | 0.0 ± 0.0 | 0.03 | 0.09 |
Hexanoylcarnitine | 0.0 ± 0.0 | 0.04 | 0.09 |
Glycine | − 0.1 ± 0.0 | 0.04 | 0.09 |
Mannitol | 0.0 ± 0.0 | 0.05 | 0.12 |
Metabolites significantly associated with NDM/LDM and with a circulating marker of carbamylation (homocitrulline/lysine) are shown with parameter estimates and standard errors (β ± SE), and with p- and q-values.